Jay Venkatesan, See Remarks at Angion Biomedica Corp. (ANGN), bought 82,200 shares at $1.23 ($101K) on 2022-05-20, disclosed to the SEC on 2022-05-25.
Open-market purchase of $101k ANGN by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.23 | 50,000 | $62K | 60.6% |
| 2 | $1.24 | 32,200 | $40K | 39.4% |
| Total | $1.23 avg | 82,200 | $101K | 100% |
| Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |
| ANGN | BUY | 2021-12-20 | $177K | — | Filing → |